BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12946709)

  • 1. Increased c-Fos expression in the centromedial nucleus of the thalamus in metabotropic glutamate 8 receptor knockout mice following the elevated plus maze test.
    Linden AM; Baez M; Bergeron M; Schoepp DD
    Neuroscience; 2003; 121(1):167-78. PubMed ID: 12946709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic administration of the potent mGlu8 receptor agonist (S)-3,4-DCPG induces c-Fos in stress-related brain regions in wild-type, but not mGlu8 receptor knockout mice.
    Linden AM; Bergeron M; Baez M; Schoepp DD
    Neuropharmacology; 2003 Sep; 45(4):473-83. PubMed ID: 12907308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytic activity of the MGLU2/3 receptor agonist LY354740 on the elevated plus maze is associated with the suppression of stress-induced c-Fos in the hippocampus and increases in c-Fos induction in several other stress-sensitive brain regions.
    Linden AM; Greene SJ; Bergeron M; Schoepp DD
    Neuropsychopharmacology; 2004 Mar; 29(3):502-13. PubMed ID: 14694349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptor.
    Linden AM; Johnson BG; Peters SC; Shannon HE; Tian M; Wang Y; Yu JL; Köster A; Baez M; Schoepp DD
    Neuropharmacology; 2002 Aug; 43(2):251-9. PubMed ID: 12213279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice.
    Linden AM; Shannon H; Baez M; Yu JL; Koester A; Schoepp DD
    Psychopharmacology (Berl); 2005 Apr; 179(1):284-91. PubMed ID: 15619115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional CRF receptor 1 knockout mice show altered neuronal activation pattern to mild anxiogenic challenge.
    Nguyen NK; Keck ME; Hetzenauer A; Thoeringer CK; Wurst W; Deussing JM; Holsboer F; Müller MB; Singewald N
    Psychopharmacology (Berl); 2006 Oct; 188(3):374-85. PubMed ID: 16953386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of c-Fos induction in the brain by the mGlu2/3 receptor antagonist LY341495 and agonist LY354740: evidence for widespread endogenous tone at brain mGlu2/3 receptors in vivo.
    Linden AM; Bergeron M; Schoepp DD
    Neuropharmacology; 2005; 49 Suppl 1():120-34. PubMed ID: 16023151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Related functions of mGlu4 and mGlu8.
    Davis MJ; Duvoisin RM; Raber J
    Pharmacol Biochem Behav; 2013 Oct; 111():11-6. PubMed ID: 23948069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual contribution of metabotropic glutamate receptor (mGlu) 2 and 3 to c-Fos expression pattern evoked by mGlu2/3 antagonism.
    Hetzenauer A; Corti C; Herdy S; Corsi M; Ferraguti F; Singewald N
    Psychopharmacology (Berl); 2008 Nov; 201(1):1-13. PubMed ID: 18813914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of lateral perforant path excitatory responses by metabotropic glutamate 8 (mGlu8) receptors.
    Zhai J; Tian MT; Wang Y; Yu JL; Köster A; Baez M; Nisenbaum ES
    Neuropharmacology; 2002 Aug; 43(2):223-30. PubMed ID: 12213276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of novelty-induced hyperlocomotion and hippocampal c-Fos expression in GluA1 knockout male mice by the mGluR2/3 agonist LY354740.
    Procaccini C; Maksimovic M; Aitta-Aho T; Korpi ER; Linden AM
    Neuroscience; 2013 Oct; 250():189-200. PubMed ID: 23867766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor subtype 4 activation is involved in anxiety and depression-like behavior in mouse models.
    Scheich B; Gaszner B; Kormos V; László K; Ádori C; Borbély É; Hajna Z; Tékus V; Bölcskei K; Ábrahám I; Pintér E; Szolcsányi J; Helyes Z
    Neuropharmacology; 2016 Feb; 101():204-15. PubMed ID: 26387439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiety behaviour of the male rat on the elevated plus maze: associated regional increase in c-fos mRNA expression and modulation by early maternal separation.
    Troakes C; Ingram CD
    Stress; 2009 Jul; 12(4):362-9. PubMed ID: 19051121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mGlu2 or mGlu3 receptor deletions on mGlu2/3 receptor agonist (LY354740)-induced brain c-Fos expression: specific roles for mGlu2 in the amygdala and subcortical nuclei, and mGlu3 in the hippocampus.
    Linden AM; Baez M; Bergeron M; Schoepp DD
    Neuropharmacology; 2006 Aug; 51(2):213-28. PubMed ID: 16733060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased measures of anxiety and weight gain in mice lacking the group III metabotropic glutamate receptor mGluR8.
    Duvoisin RM; Zhang C; Pfankuch TF; O'Connor H; Gayet-Primo J; Quraishi S; Raber J
    Eur J Neurosci; 2005 Jul; 22(2):425-36. PubMed ID: 16045496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered glutamate and GABA release within thalamocortical circuitry in metabotropic glutamate receptor 4 knockout mice.
    Wang X; Ai J; Hampson DR; Snead OC
    Neuroscience; 2005; 134(4):1195-203. PubMed ID: 16039800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia.
    Robbins MJ; Starr KR; Honey A; Soffin EM; Rourke C; Jones GA; Kelly FM; Strum J; Melarange RA; Harris AJ; Rocheville M; Rupniak T; Murdock PR; Jones DN; Kew JN; Maycox PR
    Brain Res; 2007 Jun; 1152():215-27. PubMed ID: 17434465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of neuropeptide Y Y2 receptor deletion on emotional stress-induced neuronal activation in mice.
    Nguyen NK; Sartori SB; Herzog H; Tasan R; Sperk G; Singewald N
    Synapse; 2009 Mar; 63(3):236-46. PubMed ID: 19084906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of corticotropin releasing factor-containing neurons in the rat central amygdala and bed nucleus of the stria terminalis following exposure to two different anxiogenic stressors.
    Butler RK; Oliver EM; Sharko AC; Parilla-Carrero J; Kaigler KF; Fadel JR; Wilson MA
    Behav Brain Res; 2016 May; 304():92-101. PubMed ID: 26821289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidation of the neural circuits activated by a GABA
    Pizzo R; O'Leary OF; Cryan JF
    Neuropharmacology; 2018 Jul; 136(Pt A):129-145. PubMed ID: 28734870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.